Lin Wang, Yiyun Xie, Deqiang Kong, Kang Li, Zhichao Lai, Jiang Shao, Rong Zeng, Xiao Di, Leng Ni, Yuehong Zheng, Bao Liu
{"title":"Multiple Treatment Strategies of Accessory Renal Artery Related Hypertension: Report of Two Cases and Literature Review.","authors":"Lin Wang, Yiyun Xie, Deqiang Kong, Kang Li, Zhichao Lai, Jiang Shao, Rong Zeng, Xiao Di, Leng Ni, Yuehong Zheng, Bao Liu","doi":"10.1111/jch.14916","DOIUrl":null,"url":null,"abstract":"<p><p>Renovascular hypertension (RVH) is a primary cause of secondary hypertension, primarily driven by the activation of the renin-angiotensin-aldosterone system activation. Recently, growing studies suggested accessory renal artery (ARA) might also contribute to RVH. However, the treatment of ARA-related hypertension and whether to take interventional treatment lack consensus. Herein, we report two cases of ARA-related hypertension in our hospital. Imaging studies of both patients showed ARA stenosis. One patient had ARA occlusion well-compensated through tortuous collateral branches, achieving normal blood pressure by medical treatment alone. The other patient had ARA stenosis coexisted with main renal artery stenosis, and revascularization of both arteries led to a significant postoperative reduction in blood pressure. A literature review was conducted to summarize overall treatment strategies for ARA-related hypertension and clarify the relationship between ARA and hypertension. Recent research supported an association between ARA and hypertension. While medical therapy remains the first-line treatment for ARA-related hypertension, interventional procedures should be considered for patients whose blood pressure remains uncontrolled despite conservative management.</p>","PeriodicalId":50237,"journal":{"name":"Journal of Clinical Hypertension","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jch.14916","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Renovascular hypertension (RVH) is a primary cause of secondary hypertension, primarily driven by the activation of the renin-angiotensin-aldosterone system activation. Recently, growing studies suggested accessory renal artery (ARA) might also contribute to RVH. However, the treatment of ARA-related hypertension and whether to take interventional treatment lack consensus. Herein, we report two cases of ARA-related hypertension in our hospital. Imaging studies of both patients showed ARA stenosis. One patient had ARA occlusion well-compensated through tortuous collateral branches, achieving normal blood pressure by medical treatment alone. The other patient had ARA stenosis coexisted with main renal artery stenosis, and revascularization of both arteries led to a significant postoperative reduction in blood pressure. A literature review was conducted to summarize overall treatment strategies for ARA-related hypertension and clarify the relationship between ARA and hypertension. Recent research supported an association between ARA and hypertension. While medical therapy remains the first-line treatment for ARA-related hypertension, interventional procedures should be considered for patients whose blood pressure remains uncontrolled despite conservative management.
肾血管性高血压(RVH)是继发性高血压的主要原因,主要是由肾素-血管紧张素-醛固酮系统活化引起的。最近,越来越多的研究表明,附属肾动脉(ARA)也可能导致肾血管性高血压。然而,ARA 相关高血压的治疗方法以及是否采取介入治疗尚未达成共识。在此,我们报告了本院的两例 ARA 相关高血压患者。两例患者的影像学检查均显示 ARA 狭窄。其中一名患者的 ARA 闭塞通过迂曲的侧支得到了很好的补偿,仅通过药物治疗就能使血压恢复正常。另一名患者的 ARA 狭窄与肾动脉主干狭窄并存,对两条动脉进行血管重建后,术后血压显著下降。为了总结 ARA 相关高血压的总体治疗策略并阐明 ARA 与高血压之间的关系,我们进行了文献综述。最新研究支持 ARA 与高血压之间存在关联。虽然药物治疗仍是 ARA 相关高血压的一线治疗方法,但对于保守治疗后血压仍无法控制的患者,应考虑进行介入治疗。
期刊介绍:
The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. Through its partnership with the World Hypertension League, JCH will include a new focus on hypertension and public health, including major policy issues, that features research and reviews related to disease characteristics and management at the population level.